PTC Therapeutics Inc
XMUN:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
XMUN:BH3
|
US |
|
Grizzly Discoveries Inc
F:G6H
|
CA |
|
Sitronix Technology Corp
TWSE:8016
|
TW |
|
H
|
Hikari Tsushin Inc
XMUN:HIK
|
JP |
|
H
|
HyVision System Inc
KOSDAQ:126700
|
KR |
|
G
|
Goldman Sachs Group Inc
DUS:GOS
|
US |
|
R
|
Ruanyun Edai Technology Inc
NASDAQ:RYET
|
CN |
|
Compumedics Ltd
ASX:CMP
|
AU |
|
CTEK AB (publ)
STO:CTEK
|
SE |
|
S
|
Swiss Re AG
XHAM:SR9
|
CH |
|
R
|
Ramada Investimentos e Industria SA
F:Y4E
|
PT |
|
C
|
Century Global Commodities Corp
TSX:CNT
|
HK |
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
KR |
|
Hindustan Construction Company Ltd
BSE:500185
|
IN |
|
Gold Fields Ltd
F:EDG
|
ZA |
|
B
|
Balfour Beatty PLC
OTC:BAFBF
|
UK |
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
J
|
Jabil Inc
SWB:JBL
|
US |
|
M
|
McCormick & Company Inc
DUS:MCX
|
US |
|
European Lithium Ltd
ASX:EUR
|
AU |
|
Barratt Redrow PLC
LSE:BTRW
|
UK |
Multiples-Based Value
The Multiples-Based Value for
PTC Therapeutics Inc (BH3) under the Base Case is hidden
EUR.
Compared with the current market price of 57.64 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.